Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

NCT00375934 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Postoperative

Interventions

DRUG: diclofenac potassium (XP21L)
DRUG: Placebo

Sponsor

Xanodyne Pharmaceuticals